「肝胆膵消化器病学」は横浜市立大学附属病院の消化器内科部門です


  1. Yoneda M, Imajo K, Nakajima A. Non-Invasive Diagnosis of Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2018 May 1. doi: 10.1038/s41395-018-0170-0.PubMed PMID: 29937542.
  2. Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J, Umezawa S, Uchiyama S, Matsumoto M, Nakajima A. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661. [Epub ahead of print] PubMed PMID: 29934439.
  3. Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R. Magnetic Resonance vs Transient Elastography Analysis of Patients With Non-alcoholic Fatty Liver Disease: a Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol. 2018 Jun 13. pii: S1542-3565(18)30613-X. doi: 0.1016/j.cgh.2018.05.059. [Epub ahead of print] PubMed PMID: 29908362.
  4. Umezawa S, Nagata N, Arimoto J, Uchiyama S, Higurashi T, Nakano K, Ishii N, Sakurai T, Moriyasu S, Takeda Y, Nagase H, Komatsu H, Nakajima A, Mizuki A. Contrast-enhanced CT for Colonic Diverticular Bleeding before Colonoscopy: A Prospective Multicenter Study. Radiology. 2018 Jun 12:172910. doi: 10.1148/radiol.2018172910. [Epub ahead of print] PubMed PMID: 29893642.
  5. Muto M, Matsufuji H, Taguchi T, Tomomasa T, Nio M, Tamai H, Tamura M, Sago H, Toki A, Nosaka S, Kuroda T, Yoshida M, Nakajima A, Kobayashi H, Sou H, Masumoto K, Watanabe Y, Kanamori Y, Hamada Y, Yamataka A, Shimojima N, Kubota A, Ushijima K, Haruma K, Fukudo S, Araki Y, Kudo T, Obata S, Sumita W, Watanabe T, Fukahori S, Fujii Y, Yamada Y, Jimbo K, Kawai F, Fukuoka T, Onuma S, Morizane T, Ieiri S, Esumi G, Jimbo T, Yamasaki T. Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017. Pediatr Int. 2018 May;60(5):400-410. doi: 10.1111/ped.13559. PubMed PMID: 29878629.
  6. Matsui N, Imajo K, Yoneda M, Kessoku T, Honda Y, Ogawa Y, Tomeno W, Fujisawa N, Misumi T, Kazumi K, Saito S, Nakajima A. Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices. J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298. [Epub ahead of print] PubMed PMID: 29869419.
  7. Imajo K, Tomeno W, Kanezaki M, Honda Y, Kessoku T, Ogawa Y, Yoshida K, Yoneda M, Kirikoshi H, Ono M, Kaneta T, Inoue T, Teratani T, Saito S, Nakajima A. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. J Gastroenterol Hepatol. 2018 May 30. doi: 10.1111/jgh.14294. [Epub ahead of print] PubMed PMID: 29851164.
  8. Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018 May 24. pii: S2468-1253(18)30123-7. doi: 10.1016/S2468-1253(18)30123-7. [Epub ahead of print] PubMed PMID: 29805116.
  9. Ishiba H, Sumida Y, Tanaka S, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Suzuki Y, Yoneda M, Takahashi H, Nakahara T, Seko Y, Mori K, Kanemasa K, Shimada K, Imai S, Imajo K, Kawaguchi T, Nakajima A, Chayama K, Saibara T, Shima T, Fujimoto K, Okanoue T, Itoh Y; Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD). Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. J Gastroenterol. 2018 May 25. doi: 10.1007/s00535-018-1478-7. [Epub ahead of print] PubMed PMID: 29802457.
  10. Chiba H, Ohata K, Takita M, Tachikawa J, Ashikari K, Goto T, Nakajima A. Double-tunnel method for treatment of colorectal lesions with severe fibrosis with endoscopic submucosal dissection. Endoscopy. 2018 Jul;50(7):E168-E169. doi: 10.1055/a-0599-0401. Epub 2018 May 9. PubMed PMID: 29742763.
  11. Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation. Neurogastroenterol Motil. 2018 May;30(5):e13363. doi: 10.1111/nmo.13363. PubMed PMID: 29700962.
  12. Ogawa Y, Honda Y, Kessoku T, Tomeno W, Imajo K, Yoneda M, Kawanaka M, Kirikoshi H, Ono M, Taguri M, Saito S, Yamanaka T, Wada K, Nakajima A. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14156. [Epub ahead of print] PubMed PMID: 29633352.
  13. Kessoku T, Imajo K, Kobayashi T, Honda Y, Kato T, Ogawa Y, Tomeno W, Kato S, Higurashi T, Yoneda M, Kirikoshi H, Kubota K, Taguri M, Yamanaka T, Usuda H, Wada K, Saito S, Nakajima A. Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design. Contemp Clin Trials. 2018 Jun;69:40-47. doi: 10.1016/j.cct.2018.04.002. Epub 2018 Apr 5. PubMed PMID: 29627620.
  14. Arimoto J, Higurashi T, Kato S, Fuyuki A, Ohkubo H, Nonaka T, Yamaguchi Y, Ashikari K, Chiba H, Goto S, Taguri M, Sakaguchi T, Atsukawa K, Nakajima A. Risk factors for post-colorectal endoscopic submucosal dissection (ESD) coagulation syndrome: a multicenter, prospective, observational study. Endosc Int Open. 2018 Mar;6(3):E342-E349. doi: 10.1055/s-0044-101451. Epub 2018 Mar 7. PubMed PMID: 29527556; PubMed Central PMCID: PMC5842075.
  15. Ohki K, Wakui H, Kishio N, Azushima K, Uneda K, Haku S, Kobayashi R, Haruhara K, Kinguchi S, Yamaji T, Yamada T, Minegishi S, Ishigami T, Toya Y, Yamashita A, Imajo K, Nakajima A, Kato I, Ohashi K, Tamura K. Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue. Sci Rep. 2018 Feb 12;8(1):2846. doi: 10.1038/s41598-018-21270-8. PubMed PMID: 29434287; PubMed Central PMCID: PMC5809432.
  16. Nonaka T, Inamori M, Miyashita T, Inoh Y, Kanoshima K, Higurashi T, Ohkubo H, Iida H, Fujita K, Kusakabe A, Gotoh T, Nakajima A. Can sedation using a combination of propofol and dexmedetomidine enhance the satisfaction of the endoscopist in endoscopic submucosal dissection? Endosc Int Open. 2018 Jan;6(1):E3-E10. doi: 10.1055/s-0043-122228. Epub 2018 Jan 12. PubMed PMID: 29340293; PubMed Central PMCID: PMC5766333.
  17. Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. Aliment Pharmacol Ther. 2018 Mar;47(6):816-825. doi: 10.1111/apt.14506. Epub 2018 Jan 14. PubMed PMID: 29333610.
  18. Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.Neurogastroenterol Motil. 2018 May;30(5):e13275. doi: 10.1111/nmo.13275. Epub 2017 Dec 26. PubMed PMID: 29278278.
  19. Arimoto J, Higurashi T, Chiba H, Misawa N, Yoshihara T, Kato T, Kanoshima K, Fuyuki A, Ohkubo H, Goto S, Ishikawa Y, Tachikawa J, Ashikari K, Nonaka T, Taguri M, Kuriyama H, Atsukawa K, Nakajima A. Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal Dissection. Dig Dis Sci. 2018 Jan;63(1):218-227. doi: 10.1007/s10620-017-4843-0. Epub 2017 Nov 24. PubMed PMID: 29177848; PubMed Central PMCID: PMC5760603.
  20. Yoneda M, Imajo K, Takahashi H, Ogawa Y, Eguchi Y, Sumida Y, Yoneda M, Kawanaka M, Saito S, Tokushige K, Nakajima A. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. J Gastroenterol. 2018 Feb;53(2):181-196. doi: 10.1007/s00535-017-1414-2. Epub 2017 Nov 24. Review. PubMed PMID: 29177681; PubMed Central PMCID: PMC5846871.
  21. Hotta K, Kitamoto T, Kitamoto A, Ogawa Y, Honda Y, Kessoku T, Yoneda M, Imajo K, Tomeno W, Saito S, Nakajima A. Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression. Hepatol Res. 2018 Feb;48(3):E320-E334. doi: 10.1111/hepr.12992. Epub 2017 Nov 17. PubMed PMID: 29059699.
  22. Yamada E, Namiki Y, Takano Y, Takamine H, Inazumi K, Sasaki H, Yamada M, Ito S, Iwasaki T, Mantani N, Minami T, Osada UN, Terauchi Y, Nakajima A. Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: A multicenter study. J Gastroenterol Hepatol. 2018 Apr;33(4):863-868. doi: 10.1111/jgh.14022. Epub 2018 Jan 18. PubMed PMID: 29048762.
  23. Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Prevalence of pruritus in patients with chronic liver disease: A multicenter study. Hepatol Res. 2018 Feb;48(3):E252-E262. doi: 10.1111/hepr.12978. Epub 2017 Oct 10. PubMed PMID: 28877392.
  24. Nakajima A, Seki M, Taniguchi S. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial. J Gastroenterol. 2018 Apr;53(4):525-534. doi: 10.1007/s00535-017-1383-5. Epub 2017 Aug 24. PubMed PMID: 28840422; PubMed Central PMCID: PMC5866829.

↑ PAGE TOP